SAM
TARS icon

Smartleaf Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Smartleaf Asset Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27K Hold
37
– – ﹤0.01% 2923
2026
Q1 		$2.48K Hold
37
– – ﹤0.01% 2903
2025
Q4 		$3.05K Buy
37
+10
+37% +$747 ﹤0.01% 2860
2025
Q3 		$1.57K Hold
27
– – ﹤0.01% 2665
2025
Q2 		$1.09K Buy
+27
New +$1.22K ﹤0.01% 2464
2025
Q1 		– Sell
-27
Closed -$1.48K – 2999
2024
Q4 		$1.48K Hold
27
– – ﹤0.01% 2604
2024
Q3 		$877 Buy
+27
New +$759 ﹤0.01% 2680

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Smartleaf Asset Management's TARS Position: Q2 2026 in Review

Smartleaf Asset Management held its Tarsus Pharmaceuticals (TARS) position steady in Q2 2026 at 37 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #2923.

Smartleaf Asset Management first reported a position in TARS in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.05K in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Smartleaf Asset Management held 37 shares of Tarsus Pharmaceuticals worth $2.27K as of Q2 2026.
  • Smartleaf Asset Management left its Tarsus Pharmaceuticals share count unchanged in Q2 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2923 holding.
  • Smartleaf Asset Management first reported a position in Tarsus Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Smartleaf Asset Management's Tarsus Pharmaceuticals position peaked at $3.05K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.